• Issue

    Pharmacoepidemiology and Drug Safety: Volume 32, Issue 9

    939-1052
    September 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 07 August 2023

REVIEW

Open Access

Evaluating the use of methods to mitigate bias from non-transient medications in the case-crossover design: A systematic review

Hsiao-Ching Huang,  Wen-Chin Li,  Mina Tadrous,  Glen T. Schumock,  Daniel Touchette,  Saria Awadalla,  Todd A. Lee, 
  • Pages: 939-950
  • First Published: 07 June 2023

ORIGINAL ARTICLES

Hypertension medication from guidelines to practice: A cohort study in western Iran

Foroud Shahbazi,  Farid Najafi,  Lida Shojaei,  Mohammad Hosein Farzaei,  Yalda Shokoohinia,  Yahya Pasdar,  Behrooz Hamzeh,  Reza Tahvilian,  Werya Rahimi,  Ebrahim Shakiba,  Hossein Karim,  Annette Dobson,  Neha Bhatt,  Mehdi Moradinazar, 
  • Pages: 951-960
  • First Published: 28 March 2023

Signal detection of COVID-19 vaccines adverse events using spontaneous reports from South Korea

Hye Su Jeong,  Byung Chul Chun, 
  • Pages: 961-968
  • First Published: 05 April 2023
Open Access

Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned

Timothy Beukelman,  Lang Chen,  Narender Annapureddy,  Jim Oates,  Megan E. B. Clowse,  Millie Long,  Michael D. Kappelman,  Rennie L. Rhee,  Peter A. Merkel,  William Benjamin Nowell,  Fenglong Xie,  Cassie Clinton,  Jeffrey R. Curtis, 
  • Pages: 969-977
  • First Published: 02 April 2023

Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North-East Ethiopia, 2021

Seteamlak Adane Masresha,  Atitegeb Abera Kidie,  Gedefaw Diress Alen,  Getahun Fentaw Mulaw,  Fentaw Wassie Feleke,  Mesfin Wudu Kassaw,  Tadesse Mamo Dejene, 
  • Pages: 978-987
  • First Published: 28 March 2023

Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy

Sejin Lee,  Antonia V. Bennett,  Xi Zhou,  Allison Betof Warner,  Justin G. Trogdon,  Erin E. Kent,  Jennifer L. Lund, 
  • Pages: 988-1000
  • First Published: 24 April 2023
Open Access

Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19

Mirjam Hempenius,  Sophie H. Bots,  Rolf H. H. Groenwold,  Anthonius de Boer,  Olaf H. Klungel,  Helga Gardarsdottir, 
  • Pages: 1001-1011
  • First Published: 18 April 2023

Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: Informing gestational age assumptions when clinical estimates are not available

Andrea V. Margulis,  Brian Calingaert,  Alison T. Kawai,  Elena Rivero-Ferrer,  Mary S. Anthony, 
  • Pages: 1012-1020
  • First Published: 17 April 2023

Feasibility and validity of using healthcare databases to conduct cross-national comparative studies of opioid use, its determinants and consequences

Teng-Chou Chen,  Björn Wettermark,  Douglas Steinke,  Gillian E. Caughey,  Mina Tadrous,  Veronika J. Wirtz,  Li-Chia Chen, on behalf of the Global Opioid Utilization Research Collaborative Group , 
  • Pages: 1021-1031
  • First Published: 21 March 2023
Open Access

Assessing heterogeneity of electronic health-care databases: A case study of background incidence rates of venous thromboembolism

Martin Russek,  Chantal Quinten,  Valentijn M. T. de Jong,  Catherine Cohet,  Xavier Kurz, 
  • Pages: 1032-1048
  • First Published: 17 April 2023

COMMENTARY

Mifepristone and the courts: The thread that could unravel regulation of drugs in the United States

Juan M. Hincapie-Castillo,  Michele Jonsson Funk, 
  • Pages: 1049-1051
  • First Published: 06 June 2023

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 1052
  • First Published: 07 August 2023